50 Stocks for Life: Five Pharmaceutical Stocks with Long-Term Potential | Capital+
Production of the Wegovy weight-loss injection. The shares of weight-loss injection manufacturer Novo Nordisk are a long-term runner among pharmaceutical stocks.
© Blondet Eliot/ABACA / IMAGO
The pharmaceutical industry is under pressure due to expiring patents and the tariff dispute. But this also presents opportunities. Five stocks have made it into the "50 Stocks for Life" list.
Until a few years ago, pharmaceutical stocks were practically predestined to be included in any long-term portfolio. They were a safe haven, offering high dividends and strong growth. But the coronavirus pandemic changed all that: While it suddenly boosted many pharmaceutical stocks to enormous valuations, several companies soon slid into a growth and innovation crisis.
capital.de
